Tumor necrosis factor family members and inflammatory bowel disease

被引:61
|
作者
Wang, J [1 ]
Fu, YX [1 ]
机构
[1] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
关键词
D O I
10.1111/j.0105-2896.2005.00218.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tumor necrosis factor (TNF) is one of the most potent effector cytokines in the pathogenesis of inflammatory bowel disease (IBD). Previous studies strongly implicate the critical involvement of several TNF family members in human IBD. This review focuses on the recent studies of TNF family members in IBD development. In particular, we discuss the findings about LIGHT (homologous to lymphotoxins, inducible expression, competes with herpes simplex virus glycoprotein D for herpes viral entry mediator, a receptor expressed on T lymphocytes) in the pathogenesis of IBD, and the potential mechanisms by which LIGHT induces IBD. Such mechanisms may also apply to other TNF family members.
引用
收藏
页码:144 / 155
页数:12
相关论文
共 50 条
  • [21] Tumour necrosis factor and inflammatory bowel disease
    Armstrong, AM
    Gardiner, KR
    Kirk, SJ
    Halliday, MI
    Rowlands, BJ
    BRITISH JOURNAL OF SURGERY, 1997, 84 (08) : 1051 - 1058
  • [22] Histoplasmosis in Inflammatory Bowel Disease Patients on Tumor Necrosis Factor-a Medications
    Jansson-Knodell, Claire
    Moors, Courtney
    Loftus, Edward V., Jr.
    Walker, Randall
    Enzler, Mark
    Virk, Abinash
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S378 - S378
  • [23] TUMOR-NECROSIS-FACTOR AND CACHEXIA IN CHRONIC INFLAMMATORY BOWEL-DISEASE
    OCONNELL, MA
    WEIR, DG
    KELLEHER, D
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1994, 6 (09) : 821 - 829
  • [24] Anti-Tumor Necrosis Factor Treatment of Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
    Jegadeesan, Ramprasad
    Kochhar, Gursimran
    Hayat, Umar
    Kim, Ahyoung J.
    Lan, Nan
    Sanaka, Madhusudhan R.
    Shen, Bo
    Romero-Marrero, Carlos
    GASTROENTEROLOGY, 2016, 150 (04) : S396 - S397
  • [25] Tumor Necrosis Factor Inhibitors in Inflammatory Bowel Disease and Risk of Immune Mediated Inflammatory Diseases
    Ward, Daniel
    Andersen, Nynne Nyboe
    Gortz, Sanne
    Iversen, Aske Thorn
    Allin, Kristine Hojgaard
    Beaugerie, Laurent
    Kirchgesner, Julien
    Jess, Tine
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (01) : 135 - 143
  • [26] Tumor necrosis factor receptor family members in the immune system
    Gravestein, LA
    Borst, J
    SEMINARS IN IMMUNOLOGY, 1998, 10 (06) : 423 - 434
  • [27] FECAL AND SYSTEMIC TUMOR-NECROSIS-FACTOR IN EXPERIMENTAL INFLAMMATORY BOWEL-DISEASE
    NEILLY, PJD
    CAMPBELL, GR
    ANDERSON, NH
    GARDINER, KR
    KIRK, SJ
    ROWLANDS, BJ
    BRITISH JOURNAL OF SURGERY, 1994, 81 (12) : 1817 - 1817
  • [28] Gastroenterologists Adherence to Tumor Necrosis Factor Antagonist Combination Therapy in Inflammatory Bowel Disease
    Abdullah, Israa
    Alhendi, Ghadeer
    Alhadab, Anwar
    Alasfour, Hajer
    Shehab, Mohammad
    FRONTIERS IN MEDICINE, 2021, 8
  • [29] Mucosal Gene Transcript of Tumor Necrosis Factor in Personalized Medicine of Inflammatory Bowel Disease
    Rasmus, Goll
    Renate, Meyer
    Oystein, Moe
    Johnsen, Knut
    Mona, Gundersen
    Jon, Florholmen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S9 - S9
  • [30] Progress with anti-tumor necrosis factor therapeutics for the treatment of inflammatory bowel disease
    Fernandes, Carlos
    Allocca, Mariangela
    Danese, Silvio
    Fiorino, Gionata
    IMMUNOTHERAPY, 2015, 7 (02) : 175 - 190